The Role of Sphingosine 1-Phosphate Receptor Modulators in the Treatment of Multiple Sclerosis - European Medical Journal
The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators | Neurology
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions - The Lancet
Mechanism of action of sphingosine receptor modulators. Ozanimod is an... | Download Scientific Diagram
Dritter S1P-Modulator bei Multipler Sklerose
The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases. - Abstract - Europe PMC
Action mechanism of fingolimod and other S1P receptor modulators.... | Download Scientific Diagram
Role of sphingosine 1-phosphate (S1P) and effects of fingolimod, an S1P receptor 1 functional antagonist in lymphocyte circulation and autoimmune diseases
Sphingosine-1-phosphate Receptor Modulators in Multiple Sclerosis | touchNEUROLOGY
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects | SpringerLink
Second generation S1P pathway modulators: Research strategies and clinical developments - ScienceDirect
Sphingosine-1-Phosphate Modulators for Multiple Sclerosis - Practical Neurology
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis | Semantic Scholar
S1P receptor modulators and the cardiovascular autonomic nervous system in multiple sclerosis: a narrative review - Victor Constantinescu, Rocco Haase, Katja Akgün, Tjalf Ziemssen, 2022
Cells | Free Full-Text | Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives
Sphingosine 1-phosphate receptor modulators for the treatment of inflammatory bowel disease and other immune-mediated diseases | SpringerLink